BIOMUNEX has a strong IP position. Many priority patent applications cover the platform and products, most of them have been granted. New products and inventions on the BiXAb® technology are covered by additional IP, providing further protection to BIOMUNEX inventions. Various patent applications were filed by BIOMUNEX:
- several patent applications on the BiXAb® Platform.
- several patent applications for its BiXAb® lead products with the objective of protecting all BIOMUNEX’ proprietary antibodies.